Speaking of Psychology Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD
33 snips
Nov 12, 2025 Dr. Rachel Goldman, a licensed clinical psychologist and NYU professor, dives into the world of GLP-1 drugs like Ozempic and Wegovy. She explains how these medications affect appetite and mental health, discussing both the hopes and pitfalls of weight loss. Goldman addresses the stigma surrounding GLP-1 use and emphasizes the importance of thoughtful questions before starting treatment. She explores the complexities of changes in relationships post-weight loss and dispels myths like the 'Ozempic personality.' A must-listen for anyone curious about the intersection of medication, weight, and mental well-being!
AI Snips
Chapters
Books
Transcript
Episode notes
How GLP-1s Change Appetite
- GLP-1s mimic a natural hormone that reduces appetite and cravings, helping people feel full faster.
- This biological effect lowers the "food noise" that drives overeating and supports weight loss.
Restoring Hope Through Biology
- Many patients regain hope because GLP-1s enable weight loss when diet and exercise alone failed.
- The medication can level the playing field by reducing biological resistance to weight change.
Ask Before You Start
- If you're considering GLP-1s, ask if you've been struggling with health or weight despite efforts.
- Talk with your healthcare professional when the idea has been on your mind to evaluate medical suitability.
